Home » Newsletters » BioWorld Science

BioWorld Science

Jan. 10, 2014

View Archived Issues

Mechanistic characterization of a dual function anti-inflammatory and proapoptotic drug

Preclinical development of AIC-649 as a new strategy for the treatment of chronic viral infections

Synageva provides enrollment updates on studies of enzyme replacement therapy for LAL deficiency

Eddingpharm acquires rights to several oncology assets from ACT Biotech

FDA accepts LabCorp's IDE for companion diagnostic test for ARCA biopharma's Gencaro

Apitope-led consortium receives funding to develop therapeutic vaccine for Graves' disease

Labrys Biologics begins two phase II studies of LBR-101 in chronic and episodic migraine

SOM-0226 receives FDA orphan drug designation for transthyretin amyloidosis

Targazyme presents data for ASC-101, a human recombinant enzyme-based therapy

IGN-532 shows preclinical efficacy in xenograft models of AML

Leica Biosystems to develop companion diagnostic for Arno's targeted oncology therapy onapristone

Proteon obtains E.U. orphan drug status for PRT-201 for hemodialysis vascular access

Neumedicines' HemaMax shown to improve survival outcomes following lethal irradiation

FDA approves Isentress pediatric oral suspension

Adheron Therapeutics reports phase I data for SDP-051

EMA grants accelerated review to Bristol-Myers' MAA for daclatasvir in chronic HCV

Fenfluramine obtains orphan drug designation in the U.S. and E.U. for Dravet syndrome

FLINT trial stopped early for efficacy in NASH

The Mayo Foundation discloses new STAT3 inhibitors for cancer

Aggredyne gains FDA clearance for AggreGuide A-100 instrument and AA Assay

Sanofi prepares novel dual GLP-1 and GL-R agonists

Chinese researchers disclose novel antimycobacterial agents

Sage Therapeutics synthesizes novel GABA(A) receptor modulators

Five Prime Therapeutics enters into antibody collaboration with Adimab

Hangzhou Bensheng Pharmaceutical patents new saponins for cancer

Crystal Bioscience and Boehringer Ingelheim enter therapeutic antibody collaboration

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan 23, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Jan. 23, 2026.
Cell/gene therapy sector now sustainable; China competition mounting
BioWorld
There was an upbeat message for cell and gene therapy companies in the 2026 industry update presented as the J.P. Morgan Healthcare Conference opened on Monday,...
Neurotrimin unveiled as marker in intellectual disability
BioWorld Science
Neurotrimin (NTM) is a member of the IgLON family, the disruption of which has been tied to emotional learning deficits and anxiety-like behavior in animal...
Biallelic variants in COX18 identified as cause of Charcot-Marie-Tooth disease
BioWorld Science
Charcot-Marie-Tooth (CMT) disease is a group of clinically and genetically heterogeneous sensorimotor peripheral neuropathies. It is the most frequent inherited...